Mechanism of Action of Ropeginterferon Alfa-2b in Polycythemia Vera Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mechanism of Action of Ropeginterferon Alfa-2b in Polycythemia Vera Treatment

Published:2024-05 Issue:5 Volume:46 Page:439-440
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Qin Albert^ORCID

Publisher

Elsevier BV

Reference9 articles.

1. Cancer Genome Project. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders;Baxter;Lancet,2005

2. Ruxolitinib versus best available therapy for polycythemia vera intolerant or resistant to hydroxycarbamide in a randomized trial;Harrison;J Clin Oncol,2023

3. Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment;Gisslinger;Leukemia,2023

4. JAK2V617F allele burden in polycythemia vera: burden of proof;Moliterno;Blood,2023

5. A new dosing regimen of ropeginterferon alfa-2b is highly effective and tolerable: finding from a phase 2 study in Chinese patients with polycythemia vera;Jin;Exp Hematol Oncol,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Monoclonal Antibody against PD-1 for the Treatment of Viral Oncogene-Induced Tumors or Other Cancer;Cancers;2024-09-01

2. A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis;Annals of Hematology;2024-08-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3